The latest from NuvOx

NuvOx Pharma Receives FDA Allowance to Proceed with Phase II Clinical Trial of NanO2TM

Tucson, AZ, July 29, 2021 --(PR.com)-- NuvOx Pharma, a Tucson-based biopharmaceutical company, has received notice from the FDA that they...

Tucson, AZ, July 23, 2021 --(PR.com)-- NuvOx Pharma, a privately-held clinical-stage biotechnology company based in Tucson, Arizona, has...

A tandem of homegrown Tucson drug-development companies plans to make its own drugs for testing at a new manufacturing plant — and...

A new GMP production facility including an ISO 5 cleanroom has been constructed and has initiated operations. Click here to read more...

"We are honored and excited to have Jon Saxe join our board," said Evan Unger MD, President and CEO of NuvOx. "His broad knowledge of the...

Hunniwell Lake Ventures interviews NuvOx Co-founder and CEO, Evan Unger MD.

Health Canada allows a Phase IIa Trial in COVID-19 patients with Respiratory Failure

NuvOx Pharma is breaking ground on an addition to its manufacturing facility. Read full story

Positive results of NuvOx Pharma’s NanO2 (DDFPe) in the treatment of stroke have been published at the International Stroke Conference. A...

NuvOx was awarded the TechConnect Defense Innovation Award based on the potential impact the technology will have on national security.

NuvOx was honored with the AZBIO Fast Lane Award for the company's many achievements in the last 18 months.

The NCI Grants $3M to NuvOx for a Phase II clinical trial in the brain cancer, glioblastoma.

NuvOx Pharma wins 1st place out of the biopharma companies at the MedCity INVEST Perfect Pitch Contest.

NuvOx wins 1st place out of 113 entrants and a $60,000 cash prize.